ClinicalTrials.Veeva

Menu

Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management (TELE-CVRM)

A

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Status

Not yet enrolling

Conditions

Atherosclerotic Cardiovascular Disease (ASCVD)
Hypertension
Dyslipidemia

Study type

Observational

Funder types

Other

Identifiers

NCT07208331
2025.0543

Details and patient eligibility

About

The goal of this observational study is to evaluate the implementation of a structured, digital, nurse-led, remote monitoring care pathway for cardiovascular risk management (CVRM). Participants will receive this care as part of routine clinical practice. In addition to standard follow-up, participants will complete questionnaires on quality of life, medication adherence, system usability, and patient satisfaction.

Full description

CVRM is essential for patients at increased risk of cardiovascular disease (CVD) as well as for those with established atherosclerotic cardiovascular disease (ASCVD). Monitoring blood pressure and lipid profiles is crucial to achieving guideline-recommended targets. However, many patients fail to reach these targets despite the availability of effective therapies, resulting in an increased risk of recurrent events. Meanwhile, the burden of CVD continues to rise, creating significant pressure on healthcare systems.

A digital care pathway may improve therapy adherence and outcomes by enabling personalized, data-driven care. This study evaluates the effectiveness of a nurse-led, telemonitoring pathway for CVRM in routine practice, where patients measure their blood pressure and LDL-c levels at home. The study aims to improve risk stratification, support earlier intervention, and optimize lipid and blood pressure control, ultimately leading to better patient outcomes.

Enrollment

750 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years
  • All patients enrolled in the program (high-risk and very high-risk patients)

Exclusion criteria

  • Not able to provide informed consent
  • No access to smartphone and/or tablet
  • Inability to use digital tools required for the program

Trial contacts and locations

1

Loading...

Central trial contact

Youri Schut, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems